A Project CBD Special Report on Medical Marijuana Inc., HempMeds & Kannaway
In early 2014, Project CBD assigned a writer to investigate and report on Medical Marijuana Inc., a penny stock umbrella company that markets “hemp oil” products infused with cannabidiol (CBD), a medicinal component of the cannabis plant. Originally we had hoped to shed light on the complex financial machinations of Medical Marijuana Inc., a subject that had been addressed by a few stock market analysts but not by journalists in general interest publications.
Project CBD was poised to publish Aaron Miguel Cantu’s research when we heard complaints from several sources that people were getting sick, in some cases “violently ill,” when they ingested “Real Scientific Hemp Oil,” Medical Marijuana Inc.’s flagship product. We decided to delay the release of our report until we had a chance to look into whether there was any truth to these allegations. Our investigation proceeded in an unanticipated direction, involving analytical lab tests, hemp oil production tours, and a crash course in scientific data regarding toxic solvents, heavy metals, and other contaminants.
We have presented our findings in this report.